Project Title: Novel Advanced Engineering Strategies to Optimize CAR-T Cell Function and Persistence in Multiple Myeloma (PI22/00647) Financing agency: Carlos III Health …
Analysis of the chromatin accesibility landscape and regulatory networks of igm monoclonal gammopathies: Towards a better understanding of progression mechanisms
Project title: Analysis of the chromatin accesibility landscape and regulatory networks of igm monoclonal gammopathies: Towards a better understanding of …
Immunotherapy for Multiple Myeloma
Project title: Immunotherapy for Multiple Myeloma: A New Generation of Chimeric Antigen Receptors and Immune Checkpoint Blockad (IMS_TRG_22_01) Funding agency: Sociedad …
Results-Oriented Cooperative Research Networks in Greeting 2021
Project title: Results-Oriented Cooperative Research Networks in Greeting 2021. RICORS TERAV Financing agency: Carlos III Health Institute Start and end date: 01/01/2022 …
Strategies to overcome antigen escape relapses and improve CAR T-cell persistence in multiple myeloma
Project title: Strategies to overcome antigen escape relapses and improve CAR T-cell persistence in multiple myeloma (LABAE21971FERN) Funding agency: Foundation …
Optimization of immunotherapy with CAR T cells through the inhibition of immune checkpoints to achieve a prolonged response in patients with multiple myeloma
Project title: Optimization of immunotherapy with CAR T cells through the inhibition of immune checkpoints to achieve a prolonged response in …
Phase II clinical trial on the use of a humanized CART directed against BCMA
Project title: Phase II clinical trial on the use of a humanized CART directed against BCMA (ARI0002h) in patients with …
BCMA and SLAMF7 chimeric antigen receptors T-cells immunotherapy in multiple myeloma
Project title: BCMA and SLAMF7 chimeric antigen receptors T-cells immunotherapy in multiple myeloma (BITRECS) Funding agency: European Union Start and …